FDA
-
-
-
-
-
-
-
Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors
-
-
-
-
-
-
-
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update
-
-
-
-
-
-
-
ORIC Pharmaceuticals Presents Initial Clinical Data from Phase 1b Trial of ORIC-101 in Combination with Enzalutamide and Preclinical Data on ORIC-114 at AACR-NCI-EORTC
-
-
-
-
-
-
-
ORIC Pharmaceuticals Announces FDA Clearance of IND Application for ORIC-533, a Highly Potent, Orally Bioavailable Small Molecule CD73 Inhibitor
-
-
-
-
-
-
-
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Milestones
-
-
-
-
-
-
-
ORIC Pharmaceuticals Expands Precision Oncology Pipeline with Exclusive License to Brain Penetrant EGFR/HER2 Exon 20 Inhibitor Program
-
-
-
-
-
-
323,580 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

